TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CSTL

Castle Biosciences Inc

Healthcare · Diagnostics & Research

35.20$ +0.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CSTL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – +40.6% -292.4% – – – -0.8%
– +3.9% +10.8% +31.8% +621.8% +209.5% +16.9% +29.7% +154.9%
– +170.1% +325.4% +565.3% +161.6% +67.1% +41.0% -1.8% -8.8%
– – -208.7% – +34.2% +14.9% – – –
– – – +20,690.9% -144.8% – – – –
– -44.0% +238.2% +407.0% -26.7% +61.7% +141.9% +108.0% +27.2%
– -44.0% +238.2% +406.7% +1,303.9% +149.9% -90.3% +209.8% +20.4%
– – – – – -45.8% – – –
– +3,459.9% +544.5% – – +116.1% +204.1% – –
– -78.9% +286.0% -230.8% -100.0% +1,425.0% +16.4% – -99.2%
– +78.6% +457.4% +246.5% -98.2% -72.1% -251.7% – -213.4%
– – +2,788.9% +229.6% -125.8% – – – -114.3%
– – – -15.9% -539.3% – – – -22.5%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?